Marshall Wace’s KalVista Pharmaceuticals KALV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.35M | Buy |
119,622
+38,657
| +48% | +$437K | ﹤0.01% | 1613 |
|
|
2025
Q1 | $934K | Sell |
80,965
-37,013
| -31% | -$427K | ﹤0.01% | 1708 |
|
|
2024
Q4 | $999K | Buy |
117,978
+103,072
| +691% | +$873K | ﹤0.01% | 1619 |
|
|
2024
Q3 | $173K | Sell |
14,906
-34,005
| -70% | -$394K | ﹤0.01% | 2145 |
|
|
2024
Q2 | $576K | Sell |
48,911
-579,976
| -92% | -$6.83M | ﹤0.01% | 1731 |
|
|
2024
Q1 | $7.46M | Buy |
+628,887
| New | +$7.46M | 0.01% | 748 |
|
|
2023
Q4 | – | Sell |
-51,524
| Closed | -$496K | – | 2068 |
|
|
2023
Q3 | $496K | Buy |
+51,524
| New | +$496K | ﹤0.01% | 1453 |
|
|
2023
Q1 | – | Sell |
-18,396
| Closed | -$124K | – | 2372 |
|
|
2022
Q4 | $124K | Buy |
+18,396
| New | +$124K | ﹤0.01% | 2175 |
|
|
2022
Q3 | – | Sell |
-133,687
| Closed | -$1.32M | – | 2819 |
|
|
2022
Q2 | $1.32M | Buy |
133,687
+97,328
| +268% | +$958K | ﹤0.01% | 1758 |
|
|
2022
Q1 | $536K | Buy |
+36,359
| New | +$536K | ﹤0.01% | 2083 |
|
|
2021
Q3 | – | Sell |
-16,996
| Closed | -$407K | – | 2624 |
|
|
2021
Q2 | $407K | Sell |
16,996
-20,447
| -55% | -$490K | ﹤0.01% | 1744 |
|
|
2021
Q1 | $962K | Buy |
+37,443
| New | +$962K | ﹤0.01% | 1421 |
|
|
2020
Q2 | – | Sell |
-18,454
| Closed | -$141K | – | 1737 |
|
|
2020
Q1 | $141K | Buy |
+18,454
| New | +$141K | ﹤0.01% | 1248 |
|
|
2019
Q2 | – | Sell |
-29,452
| Closed | -$843K | – | 1559 |
|
|
2019
Q1 | $843K | Buy |
+29,452
| New | +$843K | 0.01% | 982 |
|